BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38268318)

  • 1. The incremental healthcare cost associated with cancer in Belgium: A registry-based data analysis.
    Gorasso V; Vandevijvere S; Van der Heyden J; Pelgrims I; Hilderink H; Nusselder W; Demoury C; Schmidt M; Vansteelandt S; De Smedt D; Devleesschauwer B
    Cancer Med; 2024 Feb; 13(3):e6659. PubMed ID: 38268318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The non-fatal burden of cancer in Belgium, 2004-2019: a nationwide registry-based study.
    Gorasso V; Silversmit G; Arbyn M; Cornez A; De Pauw R; De Smedt D; Grant I; Wyper GMA; Devleesschauwer B; Speybroeck N
    BMC Cancer; 2022 Jan; 22(1):58. PubMed ID: 35026995
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost estimates of brain disorders in Belgium.
    Schoenen J; Gianni F; Schretlen L; Sobocki P
    Acta Neurol Belg; 2006 Dec; 106(4):208-14. PubMed ID: 17323838
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health care costs and lost productivity costs related to excess weight in Belgium.
    Gorasso V; Moyersoen I; Van der Heyden J; De Ridder K; Vandevijvere S; Vansteelandt S; De Smedt D; Devleesschauwer B
    BMC Public Health; 2022 Sep; 22(1):1693. PubMed ID: 36068519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Economic burden of lung cancer attributable to smoking in China in 2015.
    Shi JF; Liu CC; Ren JS; Parascandola M; Zheng R; Tang W; Huang HY; Li F; Wang L; Su K; Li N; Zhang K; Chen WQ; Wu N; Zou XN; Liu GX; Dai M
    Tob Control; 2020 Mar; 29(2):191-199. PubMed ID: 31073096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lyme borreliosis in Belgium: a cost-of-illness analysis.
    Geebelen L; Devleesschauwer B; Lernout T; Tersago K; Parmentier Y; Van Oyen H; Speybroeck N; Beutels P
    BMC Public Health; 2022 Nov; 22(1):2194. PubMed ID: 36443755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost of disorders of the brain in Europe 2010.
    Gustavsson A; Svensson M; Jacobi F; Allgulander C; Alonso J; Beghi E; Dodel R; Ekman M; Faravelli C; Fratiglioni L; Gannon B; Jones DH; Jennum P; Jordanova A; Jönsson L; Karampampa K; Knapp M; Kobelt G; Kurth T; Lieb R; Linde M; Ljungcrantz C; Maercker A; Melin B; Moscarelli M; Musayev A; Norwood F; Preisig M; Pugliatti M; Rehm J; Salvador-Carulla L; Schlehofer B; Simon R; Steinhausen HC; Stovner LJ; Vallat JM; Van den Bergh P; van Os J; Vos P; Xu W; Wittchen HU; Jönsson B; Olesen J;
    Eur Neuropsychopharmacol; 2011 Oct; 21(10):718-79. PubMed ID: 21924589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Economic burden of resected (stage IB-IIIA) non-small cell lung cancer in France, Germany and the United Kingdom: A retrospective observational study (LuCaBIS).
    Andreas S; Chouaid C; Danson S; Siakpere O; Benjamin L; Ehness R; Dramard-Goasdoue MH; Barth J; Hoffmann H; Potter V; Barlesi F; Chirila C; Hollis K; Sweeney C; Price M; Wolowacz S; Kaye JA; Kontoudis I
    Lung Cancer; 2018 Oct; 124():298-309. PubMed ID: 29961557
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multimorbidity healthcare expenditure in Belgium: a 4-year analysis (COMORB study).
    Tran PB; Nikolaidis GF; Abatih E; Bos P; Berete F; Gorasso V; Van der Heyden J; Kazibwe J; Tomeny EM; Van Hal G; Beutels P; van Olmen J
    Health Res Policy Syst; 2024 Mar; 22(1):35. PubMed ID: 38519938
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Italian cancer figures--Report 2015: The burden of rare cancers in Italy.
    ; Busco S; Buzzoni C; Mallone S; Trama A; Castaing M; Bella F; Amodio R; Bizzoco S; Cassetti T; Cirilli C; Cusimano R; De Angelis R; Fusco M; Gatta G; Gennaro V; Giacomin A; Giorgi Rossi P; Mangone L; Mannino S; Rossi S; Pierannunzio D; Tavilla A; Tognazzo S; Tumino R; Vicentini M; Vitale MF; Crocetti E; Dal Maso L
    Epidemiol Prev; 2016; 40(1 Suppl 2):1-120. PubMed ID: 26951748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The health and economic burden of musculoskeletal disorders in Belgium from 2013 to 2018.
    Gorasso V; Van der Heyden J; De Pauw R; Pelgrims I; De Clercq EM; De Ridder K; Vandevijvere S; Vansteelandt S; Vaes B; De Smedt D; Devleesschauwer B
    Popul Health Metr; 2023 Apr; 21(1):4. PubMed ID: 37085871
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    Östensson E; Silfverschiöld M; Greiff L; Asciutto C; Wennerberg J; Lydrup ML; Håkansson U; Sparén P; Borgfeldt C
    PLoS One; 2017; 12(6):e0179520. PubMed ID: 28651012
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The healthcare costs of treating human papillomavirus-related cancers in Norway.
    Hylin H; Thrane H; Pedersen K; Kristiansen IS; Burger EA
    BMC Cancer; 2019 May; 19(1):426. PubMed ID: 31064346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The health-related social costs of alcohol in Belgium.
    Verhaeghe N; Lievens D; Annemans L; Vander Laenen F; Putman K
    BMC Public Health; 2017 Dec; 17(1):958. PubMed ID: 29246218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The health and economic impact of acute gastroenteritis in Belgium, 2010-2014.
    Papadopoulos T; Klamer S; Jacquinet S; Catry B; Litzroth A; Mortgat L; Mamouris P; Rebolledo J; Vaes B; Van Cauteren D; Van der Heyden J; Beutels P; Devleesschauwer B
    Epidemiol Infect; 2019 Jan; 147():e146. PubMed ID: 30869061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic cost of tobacco-related cancers in Sri Lanka.
    Amarasinghe H; Ranaweera S; Ranasinghe T; Chandraratne N; Kumara DR; Thavorncharoensap M; Abeykoon P; de Silva A
    Tob Control; 2018 Sep; 27(5):542-546. PubMed ID: 29079585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Costs Attributable to Smoking in Hong Kong in 2011: A Possible Increase From 1998.
    Chen J; McGhee S; Lam TH
    Nicotine Tob Res; 2019 Mar; 21(4):505-512. PubMed ID: 29149286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-of-illness and disease burden of food-related pathogens in the Netherlands, 2011.
    Mangen MJ; Bouwknegt M; Friesema IH; Haagsma JA; Kortbeek LM; Tariq L; Wilson M; van Pelt W; Havelaar AH
    Int J Food Microbiol; 2015 Mar; 196():84-93. PubMed ID: 25528537
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic consequences of legal and illegal drugs: The case of social costs in Belgium.
    Lievens D; Vander Laenen F; Verhaeghe N; Putman K; Pauwels L; Hardyns W; Annemans L
    Int J Drug Policy; 2017 Jun; 44():50-57. PubMed ID: 28445835
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Economic burden of alcohol-related cancers in the Republic of Korea.
    Han M; Tran BT; Cho H; Oh JK
    Drug Alcohol Depend; 2020 Dec; 217():108295. PubMed ID: 32979737
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.